Epstein David R sold $27K of TEM
Epstein David R sold 370 shares of Tempus AI, Inc. (TEM) at $74.29 on 2026-11-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The transaction is a primary disclosure but of modest size, likely causing only a slight price dip.
Market read
Provides fresh insider‑sale data for TEM, useful for short‑term monitoring but low trading significance.
What to watch
Potential upcoming data releases or partnership announcements could offset the sale's impact.
Background
SEC Form 4 filing discloses a director's sale under a pre‑arranged 10b5‑1 plan.
Ticker impact
Director Epstein sold 370 shares for $27,487 via a 10b5‑1 plan, reducing his holdings to 30,474 shares.
likely slight downward pressure as the market prices the insider sale
A $27k sale by a director is small relative to market cap, but 10b5‑1 sales are often viewed as neutral to mildly negative.
Market effects
Minimal impact on the AI/health‑tech sector; insider sales are routine.
No broader regional effect.
Limited to investors tracking Tempus AI.
Counterpoint
The sale could be unrelated to fundamentals; the stock may still be undervalued.
Key entities
- CompanyTempus AI, Inc.
US‑listed AI‑driven healthcare data company (NASDAQ: TEM).
- IndividualEpstein David R.
Director of Tempus AI who executed the sale.


